Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

This study is currently recruiting participants.
Verified February 2014 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01078350
First received: February 26, 2010
Last updated: February 6, 2014
Last verified: February 2014
  Purpose

The purpose of this study is to provide a mechanism to obtain tissue specimens to be used for experimental studies before the exact histologic diagnosis is known.


Condition Intervention
Lymphoma
Hodgkin Disease
Procedure: tumor tissue aspiration
Procedure: phlebotomy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Further alalysis [ Time Frame: at collection time ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

tissues sample


Estimated Enrollment: 100
Study Start Date: May 2004
Estimated Study Completion Date: May 2099
Estimated Primary Completion Date: May 2099 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.

Criteria

Inclusion Criteria:

  • Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.

Exclusion Criteria:

  • None.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01078350

Contacts
Contact: Neyssa Marina (650) 723-5535 neyssa.marina@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Neyssa Marina    650-723-5535    neyssa.marina@stanford.edu   
Contact: Cancer Clinical Trials Office    (650) 498-7061      
Principal Investigator: Dr. Neyssa Marina         
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Dr. Neyssa Marina Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01078350     History of Changes
Other Study ID Numbers: BANKPEDSTS0001, 80003, SU-11052007-794
Study First Received: February 26, 2010
Last Updated: February 6, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Lymphoma
Hodgkin Disease

Additional relevant MeSH terms:
Hodgkin Disease
Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on April 17, 2014